查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1378928

COVID-19 診斷市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

COVID-19 Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3個工作天內

價格

概要

2022 年，全球 COVID-19 診斷市場規模達到 744 億美元。展望未來， IMARC Group預計到 2028 年該市場將達到 273 億美元。

COVID-19 診斷是指為檢測個體是否有病毒感染而進行的臨床測試。 COVID-19 是由新發現的人畜共通冠狀病毒引起的傳染病。一些常見症狀包括發燒、疲勞、乾咳、氣短、喉嚨痛和身體疼痛。病毒感染通常透過逆轉錄酶聚合酶鏈反應（RT-PCR）、抗原檢測和抗體檢測來診斷。這些測試使用試劑和試劑盒從鼻咽 (NP)、口咽 (OP) 和鼻拭子、人類唾液或血液中獲取樣本。它們廣泛應用於醫院、實驗室、診所、研究所和診斷中心。

冠狀病毒疾病的突然爆發和全球範圍內 COVID-19 病例數量的驚人增加是創造市場成長積極前景的關鍵因素之一。每日病例數的持續上升導致廣泛採用診斷測試來進行快速和全面的檢測，以便為患者提供早期治療。與此一致的是，對大規模檢測和分子診斷的需求不斷成長，推動了市場的成長。此外，各種產品創新，例如用於家庭檢測的新型抗體和血清學檢測試劑盒的推出，也是其他成長誘導因素。與傳統使用的測試套件相比，這些變體耗時更少，並且可以與基於軟體的程式整合以獲得準確的結果。其他因素，包括實施有利的政府政策以防止 COVID-19 感染進一步傳播，以及醫療基礎設施的顯著改善，尤其是在發展中經濟體，預計將推動市場成長。

本報告回答的關鍵問題

  • 2022 年全球 COVID-19 診斷市場規模有多大？
  • COVID-19 對全球 COVID-19 診斷市場有何影響？
  • 推動全球 COVID-19 診斷市場的關鍵因素是什麼？
  • 根據產品類型，全球 COVID-19 診斷市場的細分如何？
  • 根據樣本類型，全球 COVID-19 診斷市場的細分如何？
  • 根據測試類型，全球 COVID-19 診斷市場的細分如何？
  • 根據模式，全球 COVID-19 診斷市場的細分如何？
  • 根據最終用途，全球 COVID-19 診斷市場的細分如何？
  • 全球 COVID-19 診斷市場的關鍵地區有哪些？
  • 全球 COVID-19 診斷市場的主要參與者/公司有哪些？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球 COVID-19 診斷市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：依產品類型分類的市場區隔

  • 試劑和試劑盒
    • 市場趨勢與預測
  • 儀器
    • 市場趨勢與預測
  • 其他
    • 市場趨勢與預測

第 7 章：依樣本類型分類的市場區隔

  • 鼻咽拭子
    • 市場趨勢與預測
  • 口咽拭子
    • 市場趨勢與預測
  • 鼻拭子
    • 市場趨勢與預測
  • 血
    • 市場趨勢與預測
  • 其他
    • 市場趨勢與預測

第 8 章：按測試類型分類的市場

  • 分子 (RT-PCR) 檢測
    • 市場趨勢與預測
  • 基於抗原的測試
    • 市場趨勢與預測
  • 抗體（血清學）測試
    • 市場趨勢與預測
  • 其他
    • 市場趨勢與預測

第 9 章：按模式分類的市場區隔

  • 即時護理 (PoC)
    • 市場趨勢與預測
  • 非即時照護 (Non-PoC)
    • 市場趨勢與預測

第 10 章：依最終用途分類的市場細分

  • 實驗室
    • 市場趨勢與預測
  • 醫院
    • 市場趨勢與預測
  • 診斷中心和診所
    • 市場趨勢與預測
  • 其他
    • 市場趨勢與預測

第 11 章：按地區分類的市場細分

  • 北美洲
    • 美國
      • 市場趨勢與預測
    • 加拿大
      • 市場趨勢與預測
  • 亞太
    • 中國
      • 市場趨勢與預測
    • 日本
      • 市場趨勢與預測
    • 印度
      • 市場趨勢與預測
    • 韓國
      • 市場趨勢與預測
    • 澳洲
      • 市場趨勢與預測
    • 印尼
      • 市場趨勢與預測
    • 其他
      • 市場趨勢與預測
  • 歐洲
    • 德國
      • 市場趨勢與預測
    • 法國
      • 市場趨勢與預測
    • 英國
      • 市場趨勢與預測
    • 義大利
      • 市場趨勢與預測
    • 西班牙
      • 市場趨勢與預測
    • 俄羅斯
      • 市場趨勢與預測
    • 其他
      • 市場趨勢與預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢與預測
    • 墨西哥
      • 市場趨勢與預測
    • 其他
      • 市場趨勢與預測
  • 中東和非洲
    • 市場趨勢與預測
    • 按國家/地區分類的市場細分

第 12 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 13 章：價值鏈分析

第 14 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 15 章：價格分析

第16章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Becton Dickinson and Company
    • bioMerieux SA
    • Bio-Rad Laboratories
    • Danaher Corporation
    • F. Hoffman-La Roche Ltd. (Roche Holding AG)
    • Luminex Corporation
    • PerkinElmer Inc.
    • Quest Diagnostics Incorporated
    • Robert Bosch GmbH
    • Seegene Inc.
    • Siemens Aktiengesellschaft
    • Thermo Fisher Scientific Inc.
Product Code: SR112023A3552

Abstract

The global COVID-19 diagnostics market size reached US$ 74.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 27.3 Billion by 2028.

COVID-19 diagnostics refer to the clinical tests conducted to detect the presence of the viral infection among individuals. COVID-19 is an infectious disease caused by the newly discovered zoonotic coronavirus. Some common symptoms include fever, fatigue, dry cough, shortness of breath, sore throat and body aches. The viral infection is usually diagnosed through reverse transcriptase-polymerase chain reaction (RT- PCR), antigen-based and antibody testing. These tests use reagents and kits to obtain the sample from nasopharyngeal (NP), oropharyngeal (OP) and nasal swabs, human saliva or blood. They are widely used in hospitals, laboratories, clinics, research institutes and diagnostic centers.

The sudden outbreak of coronavirus disease and an alarming increase in the number of COVID-19 cases across the globe are among the key factors creating a positive outlook for the market growth. The continuous rise in the number of daily cases has led to the widespread adoption of diagnostic tests for rapid and comprehensive testing to provide early treatment to the patients. In line with this, the increasing demand for mass testing and molecular diagnostics is contributing to the market growth. Additionally, various product innovations, such as the launch of novel antibody and serology test kits for home-testing, are acting as other growth-inducing factors. In comparison to the traditionally used testing kits, these variants are less time-consuming and can be integrated with software-based programs for accurate results. Other factors, including the implementation of favorable government polices to prevent the further spread of COVID-19 infection, along with significant improvements in the healthcare infrastructure, especially in the developing economies, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global COVID-19 diagnostics market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on product type, sample type, test type, mode and end use.

Breakup by Product Type:

Reagents and Kits

Instruments

Others

Breakup by Sample Type:

Nasopharyngeal Swabs

Oropharyngeal Swabs

Nasal Swabs

Blood

Others

Breakup by Test Type:

Molecular (RT-PCR) Testing

Antigen-based Testing

Antibody (Serology) Testing

Others

Breakup by Mode:

Point-of-Care (PoC)

Non-Point-of-Care (Non-PoC)

Breakup by End Use:

Laboratories

Hospitals

Diagnostic Centers and Clinics

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories, Danaher Corporation, F. Hoffman-La Roche Ltd. (Roche Holding AG), Luminex Corporation, PerkinElmer Inc., Quest Diagnostics Incorporated, Robert Bosch GmbH, Seegene Inc., Siemens Aktiengesellschaft and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global COVID-19 diagnostics market in 2022?
  • 2. What has been the impact of COVID-19 on the global COVID-19 diagnostics market?
  • 3. What are the key factors driving the global COVID-19 diagnostics market?
  • 4. What is the breakup of the global COVID-19 diagnostics market based on the product type?
  • 5. What is the breakup of the global COVID-19 diagnostics market based on the sample type?
  • 6. What is the breakup of the global COVID-19 diagnostics market based on the test type?
  • 7. What is the breakup of the global COVID-19 diagnostics market based on the mode?
  • 8. What is the breakup of the global COVID-19 diagnostics market based on the end use?
  • 9. What are the key regions in the global COVID-19 diagnostics market?
  • 10. Who are the key players/companies in the global COVID-19 diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global COVID-19 Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Reagents and Kits
    • 6.1.1 Market Trends and Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends and Forecast
  • 6.3 Others
    • 6.3.1 Market Trends and Forecast

7 Market Breakup by Sample Type

  • 7.1 Nasopharyngeal Swabs
    • 7.1.1 Market Trends and Forecast
  • 7.2 Oropharyngeal Swabs
    • 7.2.1 Market Trends and Forecast
  • 7.3 Nasal Swabs
    • 7.3.1 Market Trends and Forecast
  • 7.4 Blood
    • 7.4.1 Market Trends and Forecast
  • 7.5 Others
    • 7.5.1 Market Trends and Forecast

8 Market Breakup by Test Type

  • 8.1 Molecular (RT-PCR) Testing
    • 8.1.1 Market Trends and Forecast
  • 8.2 Antigen-based Testing
    • 8.2.1 Market Trends and Forecast
  • 8.3 Antibody (Serology) Testing
    • 8.3.1 Market Trends and Forecast
  • 8.4 Others
    • 8.4.1 Market Trends and Forecast

9 Market Breakup by Mode

  • 9.1 Point-of-Care (PoC)
    • 9.1.1 Market Trends and Forecast
  • 9.2 Non-Point-of-Care (Non-PoC)
    • 9.2.1 Market Trends and Forecast

10 Market Breakup by End Use

  • 10.1 Laboratories
    • 10.1.1 Market Trends and Forecast
  • 10.2 Hospitals
    • 10.2.1 Market Trends and Forecast
  • 10.3 Diagnostic Centers and Clinics
    • 10.3.1 Market Trends and Forecast
  • 10.4 Others
    • 10.4.1 Market Trends and Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends and Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends and Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends and Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends and Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends and Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends and Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends and Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends and Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends and Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends and Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends and Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends and Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends and Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends and Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends and Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends and Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends and Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends and Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends and Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends and Forecast
    • 11.5.2 Market Breakup by Country

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Abbott Laboratories
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Becton Dickinson and Company
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 bioMerieux SA
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 Bio-Rad Laboratories
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 Danaher Corporation
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 F. Hoffman-La Roche Ltd. (Roche Holding AG)
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
    • 16.3.7 Luminex Corporation
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 PerkinElmer Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Quest Diagnostics Incorporated
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Robert Bosch GmbH
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Seegene Inc.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
    • 16.3.12 Siemens Aktiengesellschaft
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 Thermo Fisher Scientific Inc.
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials
      • 16.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: COVID-19 Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: COVID-19 Diagnostics Market: Sales Value (in Billion US$), 2022-2028
  • Figure 3: Global: COVID-19 Diagnostics Market: Breakup by Product Type (in %), 2022
  • Figure 4: Global: COVID-19 Diagnostics Market: Breakup by Sample Type (in %), 2022
  • Figure 5: Global: COVID-19 Diagnostics Market: Breakup by Test Type (in %), 2022
  • Figure 6: Global: COVID-19 Diagnostics Market: Breakup by Mode (in %), 2022
  • Figure 7: Global: COVID-19 Diagnostics Market: Breakup by End Use (in %), 2022
  • Figure 8: Global: COVID-19 Diagnostics Market: Breakup by Region (in %), 2022
  • Figure 9: Global: COVID-19 Diagnostics (Reagents and Kits) Market: Sales Value (in Million US$), 2022-2028
  • Figure 10: Global: COVID-19 Diagnostics (Instruments) Market: Sales Value (in Million US$), 2022-2028
  • Figure 11: Global: COVID-19 Diagnostics (Other Product Types) Market: Sales Value (in Million US$), 2022-2028
  • Figure 12: Global: COVID-19 Diagnostics (Nasopharyngeal Swabs) Market: Sales Value (in Million US$), 2022-2028
  • Figure 13: Global: COVID-19 Diagnostics (Oropharyngeal Swabs) Market: Sales Value (in Million US$), 2022-2028
  • Figure 14: Global: COVID-19 Diagnostics (Nasal Swabs) Market: Sales Value (in Million US$), 2022-2028
  • Figure 15: Global: COVID-19 Diagnostics (Blood) Market: Sales Value (in Million US$), 2022-2028
  • Figure 16: Global: COVID-19 Diagnostics (Other Sample Types) Market: Sales Value (in Million US$), 2022-2028
  • Figure 17: Global: COVID-19 Diagnostics (Molecular/RT-PCR Testing) Market: Sales Value (in Million US$), 2022-2028
  • Figure 18: Global: COVID-19 Diagnostics (Antigen-based Testing) Market: Sales Value (in Million US$), 2022-2028
  • Figure 19: Global: COVID-19 Diagnostics (Antibody-Testing- Serology) Market: Sales Value (in Million US$), 2022-2028
  • Figure 20: Global: COVID-19 Diagnostics (Other Test Types) Market: Sales Value (in Million US$), 2022-2028
  • Figure 21: Global: COVID-19 Diagnostics (Point-of-Care - PoC) Market: Sales Value (in Million US$), 2022-2028
  • Figure 22: Global: COVID-19 Diagnostics (Non-Point-of-Care - Non-PoC) Market: Sales Value (in Million US$), 2022-2028
  • Figure 23: Global: COVID-19 Diagnostics (Laboratories) Market: Sales Value (in Million US$), 2022-2028
  • Figure 24: Global: COVID-19 Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2022-2028
  • Figure 25: Global: COVID-19 Diagnostics (Diagnostic Centers and Clinics) Market: Sales Value (in Million US$), 2022-2028
  • Figure 26: Global: COVID-19 Diagnostics (Other End Uses) Market: Sales Value (in Million US$), 2022-2028
  • Figure 27: North America: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 28: United States: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 29: Canada: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 30: Asia-Pacific: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 31: China: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 32: Japan: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 33: India: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 34: South Korea: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 35: Australia: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 36: Indonesia: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 37: Others: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 38: Europe: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 39: Germany: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 40: France: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 41: United Kingdom: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 42: Italy: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 43: Spain: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 44: Russia: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 45: Others: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 46: Latin America: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 47: Brazil: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 48: Mexico: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 49: Others: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 50: Middle East and Africa: COVID-19 Diagnostics Market: Sales Value (in Million US$), 2022-2028
  • Figure 51: Middle East and Africa: COVID-19 Diagnostics Market: Breakup by Country (in %), 2022
  • Figure 52: Global: COVID-19 Diagnostics Industry: SWOT Analysis
  • Figure 53: Global: COVID-19 Diagnostics Industry: Value Chain Analysis
  • Figure 54: Global: COVID-19 Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: COVID-19 Diagnostics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: COVID-19 Diagnostics Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: COVID-19 Diagnostics Market Forecast: Breakup by Sample Type (in Million US$), 2023-2028
  • Table 4: Global: COVID-19 Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
  • Table 5: Global: COVID-19 Diagnostics Market Forecast: Breakup by Mode (in Million US$), 2023-2028
  • Table 6: Global: COVID-19 Diagnostics Market Forecast: Breakup by End Use (in Million US$), 2023-2028
  • Table 7: Global: COVID-19 Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 8: Global: COVID-19 Diagnostics Market: Competitive Structure
  • Table 9: Global: COVID-19 Diagnostics Market: Key Players